InvestorsHub Logo
icon url

sam1933

03/06/14 3:59 PM

#1583 RE: ilajkp #1582

That’s what it’s all about…and with AXXE the timing, literally, is perfect.
AXXE is a super-rare in all of Pennyland, one of a kind situation absolutely drenched with potential.

We anticipate record sales growth in 2014

Sales of our TapouT pain relief line and supplements continues to grow at a rapid rate throughout the United States," says Dr. Daniel Bagi, President of Axxess Pharma Inc.
Dr. Bagi further stated, "We anticipate record sales growth in 2014 based on our continued acceleration of month over month sales. We are now preparing to release additional high demand products in the coming months. These products have a history of generating strong residual revenues throughout North America."


The $4 million revolving line of credit with TCA will allow our company to expand worldwide, fulfil current orders and quickly become a multi-million dollar revenue generating company," said Dr. Bagi, President of Axxess Pharma Inc." Dr. Bagi further stated, "In addition to our current TapouT products, we have additional products in the pipeline for release in 2014



Axxess Pharma Inc. poised for immediate revenue:
• Goals – to reach $36 million year 4
• Product mass retail across North America
• Worldwide online sales distribution
World-wide exclusive license with TapouT® brand
• World leading athletic lifestyle brand - $350MM/yr